These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18175394)

  • 21. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
    Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic pathways in Parkinson's disease: a review.
    Jain S; Wood NW; Healy DG
    Clin Sci (Lond); 2005 Oct; 109(4):355-64. PubMed ID: 16171459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What lysosomes actually tell us about Parkinson's disease?
    Bourdenx M; Dehay B
    Ageing Res Rev; 2016 Dec; 32():140-149. PubMed ID: 26947123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW; McNaught KS
    Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathways of neurodegeneration in Parkinson's disease.
    Dawson TM; Dawson VL
    Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 protein is a component of Lewy bodies.
    Zhu X; Siedlak SL; Smith MA; Perry G; Chen SG
    Ann Neurol; 2006 Nov; 60(5):617-618. PubMed ID: 16847950
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What can we learn from genes responsible for familial forms of Parkinson's disease?].
    Brice A
    Bull Acad Natl Med; 2006 Feb; 190(2):485-96; discussion 497-8. PubMed ID: 17001874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
    Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.
    Kanthasamy A; Jin H; Mehrotra S; Mishra R; Kanthasamy A; Rana A
    Neurotoxicology; 2010 Sep; 31(5):555-61. PubMed ID: 20005250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease.
    Wang HQ; Takahashi R
    Antioxid Redox Signal; 2007 May; 9(5):553-61. PubMed ID: 17465880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant Parkinson's disease and the route to new therapies.
    Morris HR
    Expert Rev Neurother; 2007 Jun; 7(6):649-56. PubMed ID: 17563248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
    Lee JT; Wheeler TC; Li L; Chin LS
    Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.